Clinical Trial Results: Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results of flibanserin in men undergoing androgen suppression for prostate cancer have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Andrew McDonald | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-07-20